Innoviva, Inc., Director, 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 5,385,208 shares at $5.00 ($26.9M) on 2022-03-31, disclosed to the SEC on 2022-04-01.
Recurring purchase ($26.9M) by Director, 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ETTX | BUY | 2020-09-01 | $25.0M | — | Filing → |
| ETTX | BUY | 2020-06-12 | $31.7M | — | Filing → |
| ARMP | BUY | 2020-03-31 | $44.3M | — | Filing → |